Skip to main content

Jonathan Young

Analyst

UBS

Equibles does not estimate personal net worth.

About Jonathan Young

Jonathan Young is recorded as Analyst at UBS. Jonathan Young has spoken on 16 earnings calls across 4 companies, most recently for Oscar Health, Inc. on August 6, 2026. Those appearances were for Oscar Health, Inc. (OSCR), eHealth, Inc. (EHTH), Alignment Healthcare, Inc. (ALHC) and Clover Health Investments, Corp. (CLOV). The companies whose calls Jonathan Young spoke on are classified in the Healthcare and Financial Services sectors.

Jonathan Young on recent calls

“I guess when you guys think about the pricing that's being put into next year from yourself in the market um do you guys kind of see that yourselves getting uh incrementally better gna leverage um just given kind of your productivity efforts and the pricing that's going to go into the market or should it be a little…”
Analyst — UBS, Oscar Health, Inc. 2026 Second Quarter Earnings Conference Call ·
“I guess starting with kind of your bids for 27, can you talk a little bit about how you approached it? And did you kind of approach it from a more balanced perspective or were you moving a little bit more towards your same perspective on there?”
Analyst — UBS, 2Q 2026 Clover Health Earnings Conference Call ·
“Just kind of building on the the term planned uh commentary i guess what um at least one of the larger public carriers has talked about uh retaining a fair amount of their term plan members i guess how much of that uh retention that they're aiming for falls to you directly is there a way to kind of parse that in terms…”
Analyst — UBS, Q2 2026 eHealth, Inc. Earnings Conference Call ·
“I just want to go back to the cost that's coming in 3Q and 4Q. I guess, are any of these one-time in nature, or should we consider these ongoing costs?”
Analyst — UBS, Alignment Healthcare to Announce Second Quarter 2026 Financial Results and Host Conference Call Thursday, July 30, 2026 ·
“Just going back to the risk adjustment again, I guess would you say the risk adjustment was just more a function of the claims data that you're kind of seeing so far?”
Analyst — UBS, Oscar Health, Inc. Q1 FY2026 Earnings Call ·

Affiliation history

  • UBS

    Analyst

    Transcript header (unverified)

    Current

Company network

Recent activity

Show 4 earlier activities